A. Barrish

发表

Determination of the β-adrenergic blocker timolol in plasma by liquid chromatography—atmospheric pressure chemical ionization mass spectrometry

T. Olah, J. Gilbert, A. Barrish, 1993 .

The use of stable isotope labeling and liquid chromatography/tandem mass spectrometry techniques to study the pharmacokinetics and bioavailability of the antimigraine drug, MK-0462 (rizatriptan) in dogs.

G. Gatto, T. Olah, M. Dobrinska, 1996, Rapid communications in mass spectrometry : RCM.

Non-peptide αvβ3 antagonists. Part 5: identification of potent RGD mimetics incorporating 2-aryl β-amino acids as aspartic acid replacements

P. Coleman, C. Leu, S. Rodan, 2002 .

The development and cross-validation of methods based on radioimmunoassay and LC/MS-MS for the quantification of the class III antiarrhythmic agent, MK-0499, in human plasma and urine.

T. Olah, J. Ellis, T. Greber, 1995, Journal of pharmaceutical and biomedical analysis.

Determination of MK-852, a new fibrinogen receptor antagonist, in plasma and urine by radioimmunoassay.

T. Olah, A. S. Yuan, J. Gilbert, 1993, Journal of pharmaceutical and biomedical analysis.

Disposition of a novel and potent αvβ3 antagonist in animals, and extrapolation to man

S. Rodan, J. Lin, T. Prueksaritanont, 2004 .

Pharmacokinetic studies of enalaprilat in the in vitro perfused human placental lobule system.

R. K. Miller, J. Manson, J. Gilbert, 1998, Teratology.

Pharmacokinetic and fetal cardiovascular effects of enalaprilat administration to maternal rhesus macaques.

J. Manson, C. Ducsay, J. Gilbert, 1996, American journal of obstetrics and gynecology.

Non-peptide alpha(v)beta(3) antagonists. Part 5: identification of potent RGD mimetics incorporating 2-aryl beta-amino acids as aspartic acid replacements.

P. Coleman, C. Leu, S. Rodan, 2002, Bioorganic & medicinal chemistry letters.

In Vitro and in Vivo Evaluation of Dihydropyrimidinone C-5 Amides as Potent and Selective α1A Receptor Antagonists for the Treatment of Benign Prostatic Hyperplasia

J. Barrow, K. Rittle, R. Freidinger, 2000 .

Plasma timolol concentrations of timolol maleate: timolol gel-forming solution (TIMOPTIC-XE®) once daily versus timolol maleate ophthalmic solution twice daily

T. Olah, A. Barrish, J. Laurence, 2001, Documenta Ophthalmologica.

Determination of L-654,066, a new 5 alpha-reductase inhibitor in plasma by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry.

T. Olah, T. Greber, J. Gilbert, 1992, Biological mass spectrometry.

In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.

J. Barrow, K. Rittle, R. Freidinger, 2000, Journal of medicinal chemistry.

A rapid and specific assay, based on liquid chromatography-atmospheric pressure chemical ionization mass spectrometry, for the determination of MK-434 (a 5 alpha-reductase inhibitor) and its metabolites in plasma.

T. Olah, D. McLoughlin, T. Greber, 1994, Journal of pharmaceutical and biomedical analysis.